1. 6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial. Issue 10191 (29th June 2019) Authors: Earl, Helena M; Hiller, Louise; Vallier, Anne-Laure; Loi, Shrushma; McAdam, Karen; Hughes-Davies, Luke; Harnett, Adrian N; Ah-See, Mei-Lin; Simcock, Richard; Rea, Daniel; Raj, Sanjay; Woodings, Pamela; Harries, Mark; Howe, Donna; Raynes, Kerry; Higgins, Helen B; Wilcox, Maggie; Plummer, Chris; Ma... Journal: Lancet Issue: Volume 393:Issue 10191(2019) Page Start: 2599 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Association between COVID-19 burden and delays to diagnosis and treatment of cancer patients in England. (March 2022) Authors: Fox, Louis; Monroy-Iglesias, Maria J.; Aggarwal, Ajay; Haire, Kate; Purushotham, Arnie; Spicer, James; Papa, Sophie; Rigg, Anne; Dolly, Saoirse; Sullivan, Richard; Van Hemelrijck, Mieke Journal: Journal of cancer policy Issue: Volume 31(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. British Menopause Society consensus statement on the management of estrogen deficiency symptoms, arthralgia and menopause diagnosis in women treated for early breast cancer. Issue 1 (March 2019) Authors: Marsden, Jo; Marsh, Mike; Rigg, Anne Journal: Post reproductive health Issue: Volume 25:Issue 1(2019) Page Start: 21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. One Piece of the Jigsaw for the Cancer Recovery Strategy: Prevalence of COVID-19 in Patients With Cancer. (25th August 2020) Authors: Moss, Charlotte; Dolly, Saoirse; Russell, Beth; Lei, Mary; Ghosh, Sharmista; Papa, Sophie; Sullivan, Richard; Van Hemelrijck, Mieke; Rigg, Anne Journal: Cancer control Issue: Volume 27:Number 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study. Issue 6 (June 2021) Authors: Monin, Leticia; Laing, Adam G; Muñoz-Ruiz, Miguel; McKenzie, Duncan R; del Molino del Barrio, Irene; Alaguthurai, Thanussuyah; Domingo-Vila, Clara; Hayday, Thomas S; Graham, Carl; Seow, Jeffrey; Abdul-Jawad, Sultan; Kamdar, Shraddha; Harvey-Jones, Elizabeth; Graham, Rosalind; Cooper, Jack; Khan, ... Journal: Lancet oncology Issue: Volume 22:Issue 6(2021) Page Start: 765 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗